hfpef semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials Semaglutide cuts risk for worsening

As more people take semaglutide drugs to treat their diabetes or achieve weight-loss goals, more people may be at risk for this potentially serious condition

Most TB-500 products sold online lack quality testing and regulatory oversight Educational use only

Key Takeaways: GLP-1 agonists, such as Ozempic and Wegovy, carry a black box warning due to an association with thyroid cancer, particularly in individuals with RET gene mutations

Kanai Y., Lee W.S., You G., Brown D., Hediger M.A

Some healthcare providers may have insights into local resources or non-profit organizations that can assist with medication costs, making it essential for patients to engage in open discussions about their financial concerns with their care teams